We are transforming the clinical trial landscape and enable companies to “do more trials”11-50 Employees
- B2B
- Growth StageExpanding market presence
- Website
- Location
- Company size
- 11-50 people
- Company type
- Software
- Markets
DrugDev Funding
Adam Knightfalse1 investor
Investors of DrugDev
Adam Knight
Founder of Social & Sustainable Capital LLP
Chairman of Coinfloor
Trustee of The Roundhouse
Previously Global Head of Commodites at Credit Suisse / Glencore JV
Acquisitions of DrugDev
TrialNetworks
Exit